1. CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
   Ming Yuan et al, 2016, Viruses CrossRef
2. Trial Watch—Oncolytic viruses and cancer therapy
   Jonathan Pol et al, 2016, OncoImmunology CrossRef
3. Oncolytic immunotherapy: The new clinical outbreak
   Jean-François Fonteneau et al, 2016, OncoImmunology CrossRef
4. Serotype-Specific Killing of Large Cell Carcinoma Cells by Reovirus
   Emily Simon et al, 2017, Viruses CrossRef
5. The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
   Ibrahim Eissa et al, 2018, Cancers CrossRef
6. Developing Picornaviruses for Cancer Therapy
   null McCarthy et al, 2019, Cancers CrossRef
7. Viral Vector-Based Melanoma Gene Therapy
   Altijana Hromic-Jahjefendic et al, 2020, Biomedicines CrossRef
8. Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
   June Kyu Hwang et al, 2020, IJMS CrossRef
9. Coxsackievirus B3—Its Potential as an Oncolytic Virus
   Anja Geisler et al, 2021, Viruses CrossRef
10. Mechanistic Modeling of a Novel Oncolytic Virus, V937, to Describe Viral Kinetic and Dynamic Processes Following Intratumoral and Intravenous Administration
    Zinnia P. Parra-Guillen et al, 2021, Front. Pharmacol. CrossRef
11. Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy
    William J. Burnett et al, 2021, Cancers CrossRef
12. Oncolytic virus therapy in cancer: A current review
    Jonathan Santos Apolonio et al, 2021, WJV CrossRef
13. The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
    Luyao Wang et al, 2022, Front. Oncol. CrossRef
14. Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers
    Dimitrios C. Ziogas et al, 2022, Cancers CrossRef
15. Role of HMGB1 in Cutaneous Melanoma: State of the Art
    Federica Li Pomi et al, 2022, IJMS CrossRef
16. Oncolytic virus preclinical toxicology studies
    Agnija Rasa et al, 2022, J of Applied Toxicology CrossRef
17. A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
    Ann W. Silk et al, 2022, Cancer Immunol Immunother CrossRef
18. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
    Yi-Ying Wu et al, 2023, Front. Cell. Infect. Microbiol. CrossRef